- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 257/04 - Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
Patent holdings for IPC class C07C 257/04
Total number of patents in this class: 8
10-year publication summary
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2940 |
1 |
| Sumitomo Chemical Company, Limited | 8966 |
1 |
| Bar-Ilan University | 419 |
1 |
| The Florida International University Board of Trustees | 594 |
1 |
| Sun Pharmaceutical Industries Limited | 746 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2806 |
1 |
| Laurus Labs Limited | 100 |
1 |
| Sanofi | 3983 |
1 |
| Other owners | 0 |